Zeo Scientifix Inc (BPSR) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Apr 30 2026 to Apr 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Zeo Scientifix Inc   (BPSR)


Zeo Scientifix Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zeo Scientifix Inc's ROI in the second quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Zeo Scientifix Inc 's return on investment (ROI) in its second quarter of 2026

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Apr 30 2026)
II. Quarter		 (Jan 31 2026)
I. Quarter		 (Oct 31 2025)
IV. Quarter		 (Jul 31 2025)
III. Quarter		 (Apr 30 2025)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1 -1 -1 -2 -2
Return On Investment (TTM) 375.27 % - - - -
BPSR's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -4 -5 -6 -6 -5

BPSR Company Profile >> Back to BPSR Roi Comparisons >> See Annual BPSR Return On Investment



Return On Investment BPSR's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Zeo Scientifix Inc's II. Quarter Investments $ 1 Millions BPSR's Balance sheet
Zeo Scientifix Inc's II. Quarter Income $ 0 Millions Quarterly BPSR's Income Statement
BPSR's Income by Division See BPSR's Income by Division


BPSR Annual Return On Investment (Oct 31 2025)
2024		 (Oct 31 2023)
2023		 (Oct 31 2022)
2022		 (Oct 31 2021)
2021		 (Oct 31 2020)
2020
Total Investments in Millions -1 -1 2 -2 -1
Y / Y Investment Growth - - - - -
Net Income in Millions -6 -7 -9 -13 -13
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - -416.22 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BPSR's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BPSR's Competitors
Subscribers only: Roi for Zeo Scientifix Inc's Suppliers
Subscribers only: Return On Investment for BPSR's Customers

Other Ratios
BPSR's Roa BPSR's Inventory Turnover Ratio BPSR's Growth Rates BPSR's Dividend Statistics
BPSR's Profitability Ratios BPSR's Asset Turnover Ratio BPSR's Dividend Growth
BPSR's Roe BPSR's Valuation Ratios BPSR's Financial Strength Ratios BPSR's Dividend Payout Ratio



Companies with similar Return On Investment at Apr 30 2026, within Healthcare Sector ROI
Glucotrack Inc   537.70 %
Sanuwave Health Inc   313.81 %
Elutia Inc   232.45 %
Silexion Therapeutics Corp  206.92 %
Kyntra Bio Inc   155.01 %
Rigel Pharmaceuticals Inc  132.72 %
Interpace Biosciences Inc   130.15 %
Oncotelic Therapeutics Inc   129.74 %
Coherus Oncology inc   128.80 %
Petros Pharmaceuticals inc   124.23 %
Arbutus Biopharma Corp  119.86 %
Quince Therapeutics Inc   114.14 %
Capforce Inc   102.27 %
Qhslab Inc   83.28 %
Advanced Biomed Inc.  81.85 %
Entera Bio Ltd   78.23 %
Pulmatrix Inc   77.85 %
Exelixis Inc   77.71 %

Date modified: 2026-09-26T07:28:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.